Elizabeth Claus

Summary

Affiliation: Yale University
Country: USA

Publications

  1. ncbi Breast carcinoma in situ: risk factors and screening patterns
    E B Claus
    Department of Epidemiology and Public Health, P O Box 208034, Yale University School of Medicine, 60 College St, New Haven, CT 06520 8034, USA
    J Natl Cancer Inst 93:1811-7. 2001
  2. ncbi Family history of breast and ovarian cancer and the risk of breast carcinoma in situ
    Elizabeth B Claus
    Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT 06520 8034, USA
    Breast Cancer Res Treat 78:7-15. 2003
  3. ncbi Oral contraceptives and the risk of ductal breast carcinoma in situ
    Elizabeth B Claus
    Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT 06520 8034, USA
    Breast Cancer Res Treat 81:129-36. 2003
  4. pmc Mammography screening of women in their 40s: impact of changes in screening guidelines
    Lisa Calvocoressi
    Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut 06510, USA
    Cancer 112:473-80. 2008
  5. ncbi Exogenous hormone use and meningioma risk: what do we tell our patients?
    Elizabeth B Claus
    Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut, USA
    Cancer 110:471-6. 2007
  6. ncbi Quality of life for women diagnosed with breast carcinoma in situ
    Elizabeth B Claus
    Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT 06520 8034, USA
    J Clin Oncol 24:4875-81. 2006
  7. ncbi Survival rates and patterns of care for patients diagnosed with supratentorial low-grade gliomas: data from the SEER program, 1973-2001
    Elizabeth B Claus
    Department of Epidemiology and Public Health, Yale University School of Medicine, 60 College Street, PO Box 208034, New Haven, CT 06520, USA
    Cancer 106:1358-63. 2006
  8. ncbi Epidemiology of intracranial meningioma
    Elizabeth B Claus
    Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut 06520 8034, USA
    Neurosurgery 57:1088-95; discussion 1088-95. 2005
  9. ncbi Applying recursive partitioning to a prospective study of factors associated with adherence to mammography screening guidelines
    Lisa Calvocoressi
    Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT, USA
    Am J Epidemiol 162:1215-24. 2005
  10. ncbi Prevalence of BRCA1 and BRCA2 mutations in women diagnosed with ductal carcinoma in situ
    Elizabeth B Claus
    Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Conn 06520 8034, USA
    JAMA 293:964-9. 2005

Research Grants

  1. Meningioma: Risk Factors and Quality of Life
    Elizabeth B Claus; Fiscal Year: 2010
  2. Breast Carcinoma In-Situ: Mammographic Risk Factors
    Elizabeth Claus; Fiscal Year: 2007
  3. Meningioma: Risk Factors and Quality of Life
    Elizabeth Claus; Fiscal Year: 2007
  4. LONG TERM OUTCOMES FOR WOMEN WITH BREAST CA IN SITU
    Elizabeth Claus; Fiscal Year: 2004
  5. The Meningioma Consortium: Genome-Wide Association Study
    Elizabeth B Claus; Fiscal Year: 2010

Detail Information

Publications15

  1. ncbi Breast carcinoma in situ: risk factors and screening patterns
    E B Claus
    Department of Epidemiology and Public Health, P O Box 208034, Yale University School of Medicine, 60 College St, New Haven, CT 06520 8034, USA
    J Natl Cancer Inst 93:1811-7. 2001
    ..Risk factors associated with invasive breast cancer are well documented, but those associated with breast carcinoma in situ are not well defined...
  2. ncbi Family history of breast and ovarian cancer and the risk of breast carcinoma in situ
    Elizabeth B Claus
    Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT 06520 8034, USA
    Breast Cancer Res Treat 78:7-15. 2003
    ..In addition, the role of the breast cancer susceptibility genes, BRCA1 and BRCA2, in the development of BCIS is unclear...
  3. ncbi Oral contraceptives and the risk of ductal breast carcinoma in situ
    Elizabeth B Claus
    Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT 06520 8034, USA
    Breast Cancer Res Treat 81:129-36. 2003
    ..No study has examined the relationship between oral contraceptive use and the risk of non-invasive breast carcinoma, that is, breast carcinoma in situ...
  4. pmc Mammography screening of women in their 40s: impact of changes in screening guidelines
    Lisa Calvocoressi
    Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut 06510, USA
    Cancer 112:473-80. 2008
    ....
  5. ncbi Exogenous hormone use and meningioma risk: what do we tell our patients?
    Elizabeth B Claus
    Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut, USA
    Cancer 110:471-6. 2007
    ....
  6. ncbi Quality of life for women diagnosed with breast carcinoma in situ
    Elizabeth B Claus
    Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT 06520 8034, USA
    J Clin Oncol 24:4875-81. 2006
    ..Limited data exist on long-term quality of life (QOL) for women diagnosed with breast carcinoma in situ (BCIS). Participants and..
  7. ncbi Survival rates and patterns of care for patients diagnosed with supratentorial low-grade gliomas: data from the SEER program, 1973-2001
    Elizabeth B Claus
    Department of Epidemiology and Public Health, Yale University School of Medicine, 60 College Street, PO Box 208034, New Haven, CT 06520, USA
    Cancer 106:1358-63. 2006
    ..Detailed population-based estimates of long-term survival as well as patterns of care for patients with low-grade gliomas examined by age at diagnosis, gender, and race have not been widely available...
  8. ncbi Epidemiology of intracranial meningioma
    Elizabeth B Claus
    Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut 06520 8034, USA
    Neurosurgery 57:1088-95; discussion 1088-95. 2005
    ..This review highlights current knowledge of meningioma epidemiology and new directions for research efforts in this field...
  9. ncbi Applying recursive partitioning to a prospective study of factors associated with adherence to mammography screening guidelines
    Lisa Calvocoressi
    Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT, USA
    Am J Epidemiol 162:1215-24. 2005
    ..These findings suggest that recursive partitioning may be a useful statistical tool and may aid in developing interventions to promote adherence to mammography screening guidelines...
  10. ncbi Prevalence of BRCA1 and BRCA2 mutations in women diagnosed with ductal carcinoma in situ
    Elizabeth B Claus
    Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Conn 06520 8034, USA
    JAMA 293:964-9. 2005
    ..The distribution of BRCA1 and BRCA2 mutations in women diagnosed with noninvasive breast carcinoma is unknown...
  11. ncbi Survival rates in patients with low-grade glioma after intraoperative magnetic resonance image guidance
    Elizabeth B Claus
    Department of Neurosurgery, Brigham and Women s Hospital, Boston, Massachusetts, USA
    Cancer 103:1227-33. 2005
    ....
  12. ncbi A prospective study of perceived susceptibility to breast cancer and nonadherence to mammography screening guidelines in African American and White women ages 40 to 79 years
    Lisa Calvocoressi
    Department of Epidemiology and Public Health, Yale University School of Medicine, 60 College Street, New Haven, CT 06520, USA
    Cancer Epidemiol Biomarkers Prev 13:2096-105. 2004
    ....
  13. ncbi The risk of a contralateral breast cancer among women diagnosed with ductal and lobular breast carcinoma in situ: data from the Connecticut Tumor Registry
    Elizabeth B Claus
    Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT 06510, USA
    Breast 12:451-6. 2003
    ..The magnitude of this risk and the relationship between this risk and age, time since diagnosis, histologic subtype, and treatment for the first breast cancer is continuing to be defined...
  14. ncbi Active signaling by HER-2/neu in a subpopulation of HER-2/neu-overexpressing ductal carcinoma in situ: clinicopathological correlates
    Michael P Digiovanna
    Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06510, USA
    Cancer Res 62:6667-73. 2002
    ....
  15. pmc Specific genes expressed in association with progesterone receptors in meningioma
    Elizabeth B Claus
    Department of Neurosurgery, Brigham and Women s Hospital, Boston, Massachusetts, USA
    Cancer Res 68:314-22. 2008
    ..These findings suggest that PR status may be a clinical marker for genetic subgroups of meningioma and warrant further examination in a larger data set...

Research Grants15

  1. Meningioma: Risk Factors and Quality of Life
    Elizabeth B Claus; Fiscal Year: 2010
    ..This study represents the first concentrated effort to examine environmental and genetic risk factors for meningioma. ..
  2. Breast Carcinoma In-Situ: Mammographic Risk Factors
    Elizabeth Claus; Fiscal Year: 2007
    ..abstract_text> ..
  3. Meningioma: Risk Factors and Quality of Life
    Elizabeth Claus; Fiscal Year: 2007
    ..This study represents the first concentrated effort to examine environmental and genetic risk factors for meningioma. ..
  4. LONG TERM OUTCOMES FOR WOMEN WITH BREAST CA IN SITU
    Elizabeth Claus; Fiscal Year: 2004
    ..The data are unique in that epidemiologic, biologic and clinical variables will have been collected allowing us to study the relationship of these variables with long term outcome. ..
  5. The Meningioma Consortium: Genome-Wide Association Study
    Elizabeth B Claus; Fiscal Year: 2010
    ..Identification of risk loci for meningioma will likely have strong etiologic significance with importance for both prevention and treatment. ..